Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

7Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Comorbidities can influence asthma control and promote asthma exacerbations (AEs). However, the impact of multimorbidity in AEs, assessed based on long-term follow-up of patients with asthma of different degrees of severity, has received little attention in real-life conditions. Objective: To describe the epidemiological and clinical characteristics and predictors of AEs in patients who had presented at least 1 AE in the previous year in the MEchanism of Genesis and Evolution of Asthma (MEGA) cohort. Methods: The work-up included a detailed clinical examination, pulmonary function testing, fractional exhaled nitric oxide (FeNO), blood counts, induced sputum, skin prick-tests, asthma questionnaires, and assessment of multimorbidity. The number of moderate-severe AEs in the preceding year was registered for each patient. Results: The study population comprised 486 patients with asthma (23.7% mild, 35% moderate, 41.3% severe). Disease remained uncontrolled in 41.9%, and 47.3% presented ≥1 moderate-severe AE, with a mean (SD) annual exacerbation rate of 0.47 (0.91) vs 2.11 (2.82) in mild and severe asthma, respectively. Comorbidity was detected in 56.4% (66.6% among those with severe asthma). Bronchiectasis, chronic rhinosinusitis with nasal polyps, atopy, psychiatric illnesses, hyperlipidemia, and hypertension were significantly associated with AEs. No associations were found for FeNO, blood eosinophils, or total serum IgE. Sputum eosinophilia and a high-T2 inflammatory pattern were significantly associated with AEs. Multivariable regression analysis showed a significant association with asthma severity, uncontrolled disease, and low prebronchodilator FEV1/FVC. Conclusions: Our study revealed a high frequency of AE in the MEGA cohort. This was strongly associated with multimorbidity, asthma severity, poor asthma control, airflow obstruction, higher sputum eosinophils, and a very high-T2 inflammatory pattern.

References Powered by Scopus

Eosinophilic Inflammation in Asthma

2300Citations
N/AReaders
Get full text

An official American Thoracic Society/European Respiratory Society statement: Asthma control and exacerbations - Standardizing endpoints for clinical asthma trials and clinical practice

1652Citations
N/AReaders
Get full text

Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial

1582Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Bronchodilator Reversibility in the GAN Severe Asthma Cohort

10Citations
N/AReaders
Get full text

The Impact of Bronchiectasis on the Clinical Characteristics of Non-Severe Asthma

1Citations
N/AReaders
Get full text

Asthma exacerbation comorbidity index (AECI): Predicting in-hospital adverse outcomes

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Domínguez-Ortega, J., Luna-Porta, J. A., Olaguibel, J. M., Barranco, P., Arismendi, E., Barroso, B., … Quirce, S. (2023). Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity. Journal of Investigational Allergology and Clinical Immunology, 33(4), 281–288. https://doi.org/10.18176/jiaci.0816

Readers over time

‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

Researcher 6

55%

PhD / Post grad / Masters / Doc 4

36%

Lecturer / Post doc 1

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

50%

Biochemistry, Genetics and Molecular Bi... 2

25%

Social Sciences 1

13%

Psychology 1

13%

Save time finding and organizing research with Mendeley

Sign up for free
0